Blood-brain barrier penetration of cefepime after neurosurgery

Chinese Medical Journal

Volumn 120, Issue 13, 2007, Pages 1176-1178

  Wang, Jiang Fei ^a   Wang, Qiang ^a   Zhao, Li Hong ^a   Shi, Guang Zhi ^a   Zhou, Jian Xin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Blood brain barrier; Cefepime; Drug concentration; High pressure liquid chromatography

Indexed keywords

CEFEPIME;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFECTION; BRAIN VENTRICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG PENETRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTENSIVE CARE UNIT; LUMBAR PUNCTURE; MINIMUM INHIBITORY CONCENTRATION; NEUROSURGERY; POSTOPERATIVE INFECTION;

EID: 34547500728     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200707010-00012     Document Type: Article

References (16)

1. Saez-Llorens X, Castano E, Garcia R, Baez C, Perez M, Tejeira F, et al. Prospective randomized comparison of cefepime and cefotaxime for treatmeant of bacterial meningitis in infants and children. Antimicrob Agents Chemother 1995; 39: 937-940.
2. Rhoney DH, Tam VH, Parker D Jr, Mckinnon PS, Coplin WM. Disposition of cefepime in the central nervous system of patients with external ventricular drains. Pharmacotherapy 2003; 23: 310-314.
3. Blumer JL, Reed MD, Knupp C. Review of the pharmacokinetics of cefepime in children. Pediatr Infect Dis J 2001; 20: 337-342.
4. Saez-Llorens X, O'Ryan M. Cefepime in the empiric treatment of meningitis in children. Pediatr Infect Dis J 2001; 20: 356-361.
5. Burgess DS, Hastings RW, Hardin TC. Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion. Clin Ther 2000; 22: 66-75.
6. Elkhaili H, Linger L, Monteil H, Jehl F. High-performance liquid chromatographic assay for cefepime in serum. J Chromatogr B Biomed Sci Appl 1997; 690: 181-188.
7. Cherti N, Kinowski JM, Lefrant JY, Bressolle F. High-performance liquid chromatographic determination of cefepime in human plasma and in urine and dialysis fluid using a column-switching technique. J Chromatogr B Biomed Sci Appl 2001; 754: 377-386.
8. Breilh D, Lavallee C, Fratta A, Ducint D, Cony-Makhoul P, Saux MC. Determination of cefepime and cefpirome in human serum by high-performance liquid chromatography using an ultrafiltration for antibiotics serum extraction. J Chromatogr B Biomed Sci Appl 1999; 734: 121-127.
9. Calahorra B, Campanero MA, Sadaba B, Azanza JR. Rapid high-performance liquid chromatographic determination of cefepime in human plasma. Biomed Chromatogr 1999; 13: 272-275.
10. Dai ZY. Practical materia medica of antibiotics, 2nd ed. Shanghai: Shanghai Science and Technology Publishing House; 1998: 143-145.
11. Zhu J, Tang Y, Chen R. In vitro antimicrobial activity of cefepime, a forth generation cephalosporin, compared with other five β-lactams. Chin New Drug J (Chin) 1999; 8: 238-240.
12. Jones RN, Sader HS, Beach ML. Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18 569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001). Int J Antimicrob Agents 2003; 22: 551-556.
13. Chang YL, Chou MH, Lin MF, Chen CF, Tsai TH. Effect of cyclosporine, a P-glycoprotein inhibitor, on the pharmacokinetics of cefepime in rat blood and brain: a microdialysis study. Life Sci 2001; 69: 191-199.
14. Kroll RA, Neuwelt EA. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 1998; 42: 1083-1099.
15. Lodise TP, Rhoney DH, Tam VH, McKinnon, Drusano GL. Pharmacodynamic profiling of cefepime in plasma and cerebrospinal fluid of hospitalized patients with external ventriculostomies. Diagn Microbiol Infect Dis 2006; 54: 223-230.
16. Rhoney DH, Tam VH, Parker D, McKinnon PS, Coplin WM. Disposition of cefepime in the central nervous system of patients with external ventricular drains. Pharmacotherapy 2003; 23: 310-314.